FDA Clears ImaCor’s ClariTEE Probe

The ClariTEE miniaturized transesophageal echocardiography probe facilitates episodic monitoring of cardiac function. It is a single-use device that can remain indwelling for up to 72 hours, allowing intensivists and anesthesiologists to periodically assess cardiac preload and left ventricular systolic function over a prolonged period of time.